Women often face unique challenges on their health journey, sometimes encountering overlooked, misdiagnosed, or particularly complex health issues. From rare cancers linked to environmental exposures to hormonal imbalances that profoundly impact daily life, understanding these conditions is critical.
This article, based on recent reports, will focus on mesothelioma—emphasizing the urgency of raising awareness and ensuring timely, accurate diagnosis. Data from the National Cancer Institute indicates that women account for a significant proportion of mesothelioma diagnoses, representing 29% of all cases in the United States.
Although men have historically been diagnosed at higher rates, increased awareness and improved diagnostic techniques are driving an upward trend in incidence among women. While rare in women, personal experiences highlight the often unexpected nature of diagnosis.
Mesothelioma survivor Kim Madril shared her experience visiting a specialist, recalling, “I could see it on her face. She couldn’t believe I had mesothelioma.” This underscores the deeply ingrained perception in the medical community that mesothelioma is primarily a disease affecting men.
Key data further illuminate the current state of mesothelioma in women. Of the approximately 3,000 new cases diagnosed annually in the United States, 29% are women. Notably, women appear to have higher survival rates than men. For example, 45% of female patients survive one year after diagnosis, compared to 38% of men.Looking at longer-term outcomes, the five-year survival rate for women with pleural mesothelioma is 16.4%, significantly higher than the 7.3% for men with the same type of cancer.
However, the situation is not entirely optimistic; the U.S. Centers for Disease Control and Prevention reported a concerning trend: the mortality rate for women with mesothelioma increased by 25% between 1999 and 2020.This suggests that past exposures continue to have an impact, and the disease remains a significant challenge.
Women may have better overall health at diagnosis, which may make them more suitable candidates for aggressive treatments such as surgery. Research is exploring the role of hormonal factors, particularly estrogen, with some studies suggesting that estrogen may influence tumor growth and lead to less aggressive mesothelioma in some women.
The U.S. Centers for Disease Control and Prevention (CDC) report on the rising incidence of mesothelioma in women indicates that the most common settings for asbestos exposure include homemakers, teachers, and nurses. Homemakers account for 22.8% of mesothelioma deaths among women, the highest proportion.
This is likely linked to secondary asbestos exposure, such as cleaning contaminated work clothes brought home by family members. Teachers account for 5.6% of deaths, and nurses account for 4.9%. Asbestos residues in older school and hospital buildings continue to pose risks to those working in these environments.
Even jobs unrelated to asbestos production may result in long-term exposure due to aging or damaged asbestos-containing building materials. Long-term work in old public buildings, such as the school where teacher Hatsie H. worked for 37 years, may lead to increased incidence rates among these female workers.
Recognizing the symptoms of mesothelioma in women is crucial for early intervention, although this can be challenging as these symptoms often overlap with those of more common and less severe conditions. Symptoms vary depending on the type of mesothelioma.
Women with pleural mesothelioma (affecting the inner lining of the lungs) often report shortness of breath, chest pain, fluid buildup around the lungs (pleural effusion), and chronic cough. For patients with peritoneal mesothelioma (affecting the peritoneum), symptoms often include abdominal swelling and pain, bloating, nausea, and digestive discomfort.
Core symptoms are generally the same in men and women. However, since mesothelioma is rare in women, its symptoms are often mistaken for other conditions such as asthma, irritable bowel syndrome, or hormonal changes, leading to delayed diagnosis and treatment, which can have serious consequences.
A study published in Frontiers in Cardiovascular Medicine in 2024 pointed out that women often face multiple misdiagnoses, which can lead to delayed treatment and potentially worsen outcomes. Survivor Tamron Little’s experience perfectly illustrates this point.
She was diagnosed with peritoneal mesothelioma during her pregnancy, after doctors initially believed she had uterine fibroids.Tamron shared, “After the tumor was surgically removed, it was diagnosed as peritoneal mesothelioma,” emphasizing the unexpected turn in the diagnostic process. Another case study published in October 2024 also confirmed this, reporting a woman who was initially diagnosed with an ovarian mass and later diagnosed with peritoneal mesothelioma.These cases underscore the importance of raising awareness among healthcare providers about the possibility of mesothelioma in women—even when symptoms are atypical—which is critical for improving early detection and ultimately survival outcomes.
Treatment options for mesothelioma in women are similar to those for men and include chemotherapy, combination or multimodal therapy, immunotherapy, radiation therapy, and surgery. Encouragingly, research consistently shows that women tend to have better treatment outcomes.
:max_bytes(150000):strip_icc()/close-up-of-woman-with-bleeding-nose-1180586363-a44410be16484bd3b4f10fbc4a04078a.jpg)
Despite improvements in overall survival rates, gender disparities in access to treatment remain concerning. An analysis of over 18,000 patients in the National Cancer Database revealed that while women had a 17% lower risk of death than men, they were significantly less likely to receive surgery or chemotherapy.
This trend holds true across all disease stages, particularly in epithelioid mesothelioma, a type of cancer that typically derives the greatest survival benefit from these treatments.Additionally, a 2024 analysis of inpatient data revealed that while men had higher mortality rates, women faced more complications and longer hospital stays following treatment.
This underscores the urgent need for more personalized postoperative care for women, the development of gender-sensitive treatment protocols, and strengthened patient advocacy to ensure women have access to appropriate and beneficial treatments.
Related posts:
Women & Mesothelioma: Differences in Prognosis & Exposure
‘Was diagnosed at 14; I felt my body has betrayed me’ | Life with PCOD
Endometrial cancer – Symptoms and causes
